Biopolym. Cell. 2022; 38(1):3-8.
The use of probiotic microorganisms in cosmeceuticals
1Voloshyna I. M., 2Shkotova L. V.
  1. Kyiv National University of Technologies and Design
    2, Nemirovich-Danchenko Str., Kyiv, Ukraine, 01011
  2. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03143


Normal microflora of human skin and the development of its representatives depending on the skin pH are considered in this article. It is shown a possibility of using probiotic microorganisms of genera Bifidobacterium, Lactobacillus, Lactococcus, Bacillus and their metabolites for making the cosmetic medical remedies for different skin types. It was revealed that the probiotic microorganisms’ lysates contain a large amount of biologically active substances that contribute to the recovery of the skin epidermis and inhibit the development of pathogenic skin microflora.
Keywords: probiotics, cosmeceuticals, Bifidobacterium, Lactobacillus, Lactococcus, Bacillus


[1] Boxberger M, Cenizo V, Cassir N, La Scola B. Challenges in exploring and manipulating the human skin microbiome. Microbiome. 2021; 9(1):125.
[2] Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC, Lai HC. Next generation probiotics in disease amelioration. J Food Drug Anal. 2019; 27(3): 615-22.
[3] Gueniche A, Pub. Date 9.09.2010. Use of probiotic microorganisms to limit skin irritation Pat. US 20100226892 A1.
[4] Roudsari MR, Karimi R, Sohrabvandi S, Mortazavian AM. Health effects of probiotics on the skin. Crit Rev Food Sci Nutr. 2015; 55(9):1219-40.
[5] Adu SA, Naughton PJ, Marchant R, Banat IM. Microbial biosurfactants in cosmetic and personal skincare pharmaceutical formulations. Pharmaceutics. 2020; 12(11):1099.
[6] Amar D, Bernard B, Bernard D, Castiel I, Pub. Date 29.12.2009. Cosmetic combination of microorganism and phytosphingosine derivative. Pat. RU 2428967 C1.
[7] Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol. 2011; 131: 1974-980.
[8] Singh G, Kumar D, Singh M, Sharma D, Kaur S. Emerging techniques and challenges in colon drug delivery systems. J Appl Pharm Sci. 2012; 2(03): 139-147.
[9] Godoy-Vitorino F. Human microbial ecology and the rising new medicine. Annals of translational medicin. 2019; 7(14): 342.
[10] Voloshyna IM, Shkotova LV, Skorokhod SO, Appolonova IYe, Zholobak NM. Lactobacillus bacteria: biological and therapeutic properties. Mikrobiol Z. 2019; 81(6):131-46.
[11] Schetko VA, Golovneva NA, Riabaia NE, Hrel MV, Samartsev AA. Pub. Date 2010.12.30. Strain Bifidobacterium adolescentis BIM B-456D forobtaining probiotic drugor or starter culture. Pat. BY 13853 C1.
[12] Erdakova, VP, Poznyakovsky, VM, Vekovtsev, AA. Promising approach to the creation of a new dietary supplement "Probinorm" for the prevention of skin diseases. Russ. Technique Technol. 2009; Food Prod. 01: 35-39.
[13] Voloshyna IM, Soloshenko KI, Krasinko VO, et al. Bacteriocins Lactobacillus - an alternative to antimicrobial drugs. Biopolym Cell. 2021; 37(2): 85-97.
[14] Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol. 2017; 8:1490.
[15] Castiel I, Gueniche A, Bernard D. Pub. Date 27.02.20. Cosmetic use of a lysate of Bifidobacterium species for treating body odor. Pat. EP 2560609 A1.
[16] Otieno DO, Ashton JF, Shah NP. Evaluation of enzymic potential for biotransformation of isoflavone phytoestrogen in soymilk by Bifidobacterium animalis, Lactobacillus acidophilus and Lactobacillus casei. Food Res. 2006; 39: 394-407.
[17] Vieira RP, Fernandes AR, Kaneko TM, Consiglieri VO, Sales CA, Physical and physicochemical stability evaluation of cosmetic formulations containing soybean extract fermented by Bifidobacterium animalis. 2009; Braz J Pharm. Sci. 45: 515-25.
[18] Fuchs-Tarlovsky V, Marquez-Barba MF, Sriram K. Probiotics in dermatologic practice. Nutrition. 2016; 32(3):289-95.
[19] Durand H. Pub. Date 23.04.2009. Use of lactic bacteria for the prophylaxis and/or treatment of skin diseases. Pat. WO2009050677A2.
[20] Yang JJ, Niu CC, Guo XH. Mixed culture models for predicting intestinal microbial interactions between Escherichia coli and Lactobacillus in the presence of probiotic Bacillus subtilis. Benef Microbes. 2015; 6(6):871-877.
[21] Goodarzi A, Mozafarpoor S, Bodaghabadi M, Mohamadi M. The potential of probiotics for treating acne vulgaris: A review of literature on acne and microbiota. Dermatol Ther. 2020; 33(3):e13279.
[22] Belyavskaya VA, Soro'swaku IB, Romashova NG, Kashperova TA, Masycheva VI, et. al. Pub. Date 20.08.2001. Strainof bacterial Bacillus licheniformis showing antiviral and antibacterial activity. Pat. RU 2172343 C2.
[23] Guo X, Li D, Lu W, Piao X, Chen X. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs. Antonie Leeuwenhoek. 2006; 90:139-146.
[24] Lelyak AI, Malyarchuk AA. Pub. Date 20.01.2008. Curative-cosmeticpreparation. Pat RU 2314792 C1.
[25] Salazar-Marroquín EL, Galán-Wong LJ, Moreno-Medina VR, Reyes-López MÁ, Pereyra-Alférez B. Bacteriocins synthesized by Bacillus thuringiensis: generalities and potential applications. Rev Med Microbiol. 2016; 27(3):95-101.
[26] Kaboré D, Nielsen DS, Sawadogo-Lingani H, Inhibition of Bacillus cereus growth by bacteriocin producing Bacillus subtilis isolated from fermented baobab seeds (maari) is substrate dependent. Int J Food Microbiol. 2013; 162(1):114-119.